The Nodify XL2™ test is designed to help identify likely benign lung nodules with a simple blood-based test.
Simple. Integrated. Reassuring.
Nodify XL2 Testing Can Help You
Who is Right For Nodify XL2 Testing?
Nodify XL2 is intended for patients:
- ≥40 years old
- Low to moderate risk nodules between 8-30 mm
- ≤50% risk as assessed by the Solitary Pulmonary Nodule Calculator
Incorporating Nodify XL2 In Your Nodule Workflow
Clinically Validated Results
Nodify XL2 testing supports highly accurate identification of benign lung nodules with a median Negative Predictive Value (NPV) of 98% for incidental, low to moderate risk lung nodules (risk ≤50%, 8-30mm in diameter).READ THE PANOPTIC PUBLICATION
READ THE PANOPTIC EDITORIAL